Bibliographic citations
Allauca, J., (2009). Prevalencia de síndrome metabólico y asociación con niveles séricos de ácido úrico en una población limeña [Tesis, Universidad Nacional Mayor de San Marcos]. https://hdl.handle.net/20.500.12672/1629
Allauca, J., Prevalencia de síndrome metabólico y asociación con niveles séricos de ácido úrico en una población limeña [Tesis]. PE: Universidad Nacional Mayor de San Marcos; 2009. https://hdl.handle.net/20.500.12672/1629
@misc{renati/477886,
title = "Prevalencia de síndrome metabólico y asociación con niveles séricos de ácido úrico en una población limeña",
author = "Allauca Espino, Javier Edilberto",
publisher = "Universidad Nacional Mayor de San Marcos",
year = "2009"
}
In a population of Lima, the prevalence of the next risk factors of cardiovascular disease has determinated: Obesity (BMI and Waist/Hip Ratio), elevated tryglicerides, divinised HDL Cholesterol, elevated fasting glucose and elevated Arterial Pressure; for determine the prevalence of Metabolic Syndrome. Also, the serum uric acid levels were determined in the same population and then, the association between serum uric acid levels and presence or absence of metabolic syndrome in population differenced by sex, were evaluated. It has showed no relation between the values of IMC and ICC to define obesity, due to the low level of correlation between both variables (0.406). The prevalence of each risk factor (obesity: 72.34 % in man and 64.71 % in woman; elevated triglycerides: 40.43 % in man and 41.18 % in women; low levels of HDL Cholesterol: 42.55 % in man and 64.71 % in women; elevated fasting glucose: 27.66 % in man and 37.25 % in women; elevated blood pressure: 8.51 % in man and 19.61 % in women), determine a prevalence of Metabolic Syndrome of 40.82 % in the total population, being no statistically significant difference between the male population (36.17 %) and the female population (45.10 %). There were found significant differences in the serum uric acid levels between the male population (5.31 mg %) and the female population (3.73 mg %), thus the evaluation of its association with the prevalence of Metabolic Syndrome have been realized in sex differenced populations. In the evaluation of association, we found statistical diference in the female population but not in the male population.
This item is licensed under a Creative Commons License